A twice-yearly injection could help Australia eliminate HIV, but experts are sounding the alarm over its prohibitive cost.

Merck MRK announced that the FDA has accepted for review the new drug application (“NDA”) seeking approval for its ...

There is widespread hope for curbing HIV after the United States Food and Drug Administration (FDA) approved an injectable ...

A journey through the FDA’s newly released complete response letters gave glimpses into the journeys to market for Eli ...

Trump administration funding cuts and dismantling of USAID force a shift from HIV elimination back to treatment.

Government should increase their allocation to the health sector to at least 15 percent of the total National Budget ...

Gilada, the only Indian serving on the International AIDS Society (IAS) Governing Council, assured the country has the ...

About 17,000 people are set to benefit from free access to the long-acting HIV prevention injection, lenacapavir, which only needs to be administered twice a year. This follows a new ...

The report emphasises the urgent need for countries to implement radical changes in their HIV programming and funding ...

Funding cuts to the global HIV response could trigger a surge of 6 million new infections and 4 million AIDS-related ...

Global progress against AIDS is at risk as US funding cuts threaten life-saving programs. Experts warn of millions of ...

GENEVA/JOHANNESBURG - UNAIDS today launched its 2025 Global AIDS Update, AIDS, Crisis and the Power to Transform, which shows ...